Assignee
GILEAD PHARMASSET LLC
US·55 granted patents·29 pending applications·835 citations·filing 2012–2020
Top patents by PatentIndex Score
84 records- 0199US8906880B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 9, 2014·65 cites·11 claims
- 0298US9085573B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2013·Granted Jul 21, 2015·54 cites·28 claims
- 0398US8957046B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2014·Granted Feb 17, 2015·51 cites·2 claims
- 0497US9284342B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Mar 15, 2016·23 cites·9 claims
- 0597US9221833B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Granted Dec 29, 2015·20 cites·1 claims
- 0697US8921341B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2013·Granted Dec 30, 2014·31 cites·7 claims
- 0797US8633309B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 21, 2014·44 cites·12 claims
- 0897US8629263B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 14, 2014·62 cites·25 claims
- 0996US9051340B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Jun 9, 2015·20 cites·1 claims
- 1096US8957045B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Feb 17, 2015·39 cites·20 claims
- 1196US8735569B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted May 27, 2014·48 cites·6 claims
- 1295US9585906B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2015·Granted Mar 7, 2017·11 cites·10 claims
- 1395US9549941B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 24, 2017·39 cites·23 claims
- 1495US9393256B2Methods for treating HCVGILEAD PHARMASSET LLC·Filed 2013·Granted Jul 19, 2016·42 cites·4 claims
- 1595US8889159B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2012·Granted Nov 18, 2014·114 cites·37 claims
- 1694US9511056B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 6, 2016·7 cites·9 claims
- 1793US9206217B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Dec 8, 2015·16 cites·4 claims
- 1892US9868745B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 16, 2018·8 cites·9 claims
- 1992US8969588B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2013·Granted Mar 3, 2015·17 cites·17 claims
- 2091US10086011B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Oct 2, 2018·8 cites·19 claims
- 2191US9757406B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Sep 12, 2017·9 cites·16 claims
- 2291US9296777B22′,4′-substituted nucleosides as antiviral agentsGILEAD PHARMASSET LLC·Filed 2014·Granted Mar 29, 2016·11 cites·11 claims
- 2390US11116783B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Granted Sep 14, 2021·2 cites·58 claims
- 2490US9056860B2Synthesis of antiviral compoundGILEAD PHARMASSET LLC·Filed 2013·Granted Jun 16, 2015·23 cites·13 claims
- 2589US10807990B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Granted Oct 20, 2020·1 cites·2 claims
- 2689US9884873B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2017·Granted Feb 6, 2018·6 cites·20 claims
- 2789US9630972B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Apr 25, 2017·6 cites·10 claims
- 2888US9981955B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted May 29, 2018·2 cites·20 claims
- 2988US9637512B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2014·Granted May 2, 2017·3 cites·5 claims
- 3086US10604530B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2017·Granted Mar 31, 2020·2 cites·20 claims
- 3186US9809600B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Nov 7, 2017·2 cites·2 claims
- 3286US9394331B22′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infectionsGILEAD PHARMASSET LLC·Filed 2014·Granted Jul 19, 2016·6 cites·40 claims
- 3385US10100076B2Modified nucleosides for the treatment of viral infections and abnormal cellular proliferationGILEAD PHARMASSET LLC·Filed 2013·Granted Oct 16, 2018·6 cites·5 claims
- 3485US9718807B2Synthesis of antiviral compoundGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 1, 2017·6 cites·10 claims
- 3584US10800789B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Granted Oct 13, 2020·1 cites·2 claims
- 3684US10183037B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2017·Granted Jan 22, 2019·2 cites·19 claims
- 3784US9890134B2Processes for preparing antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Feb 13, 2018·4 cites·14 claims
- 3883US9139570B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Sep 22, 2015·3 cites·5 claims
- 3982US9682989B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Granted Jun 20, 2017·2 cites·8 claims
- 4082US9676808B22′,4′-substituted nucleosides as antiviral agentsGILEAD PHARMASSET LLC·Filed 2016·Granted Jun 13, 2017·2 cites·1 claims
- 4181US10584109B2Processes for preparing antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 10, 2020·2 cites·3 claims
- 4281US9670187B2Processes for preparing antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Granted Jun 6, 2017·3 cites·19 claims
- 4380US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 4480US9682987B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Jun 20, 2017·2 cites·3 claims
- 4577US10577359B2Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2017·Granted Mar 3, 2020·1 cites·2 claims
- 4677US9624183B2Process for the preparation of a fluorolacton derivativeGILEAD PHARMASSET LLC·Filed 2015·Granted Apr 18, 2017·2 cites·16 claims
- 4776US2021053981A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Application pending·0 cites
- 4875US10039779B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 7, 2018·1 cites·16 claims
- 4974US9340568B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Granted May 17, 2016·4 cites·10 claims
- 5074US2020188419A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GILEAD PHARMASSET LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →